AMIDERM
AMIDERM
Not authorised
- Hydroxyzine hydrochloride
- Chlorphenamine maleate
Product identification
Medicine name:
AMIDERM
Active substance:
- Hydroxyzine hydrochloride
- Chlorphenamine maleate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Hydroxyzine hydrochloride25.00/milligram(s)1.00Tablet
-
Chlorphenamine maleate1.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QR06AB54
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- ARRIGONI Patrice Antoine Gaston
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratoires Biove
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/5399033 8/1992
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
